Firms To Watch: Industry focus: healthcare and life sciences

La Gro Geelkerken advocaten, having been bolstered by the arrival of Marleen van den Horst, advises on a range of clinical trial, competition, and healthcare procurement program related mandates.
In Utrecht, Van Benthem & Keulen is known for handling medical malpractice and medical disciplinary disputes. The team is led by Wouter Koelewijn and Petra Klein Gunnewiek.

Industry focus: healthcare and life sciences in Netherlands

Allen & Overy LLP

Praised for having the ‘highest level of ambition’, the team at Allen & Overy LLP leverages its network of offices across Europe to advise its varied client base of medtech and biotech companies as well as financial institutions. IP litigator Frits Gerritzen and Christiaan De Brauw jointly head the practice. Gerritzen is known for his vast knowledge of patent enforcement actions and the validity of IP rights, particularly in relation to medical equipment and antibodies, while de Brauw has vast transactional expertise, advising pharma and biotech clients on IPOs, public takeovers, and public M&A. Leading the firm’s investment management practice, Ellen Cramer de Jong advises investors on regulatory and corporate issues.

Responsables de la pratique:

Frits Gerritzen; Christiaan de Brauw


Autres avocats clés:

Ellen Cramer-de Jong; Jort de Groodt; Sophie Van Asten


Les références

‘Frits Gerritzen has a wealth of experience in pan-European life sciences patent litigations. He is supported by associate Sophie van Asten.’

‘Frits Gerritzen leads the life sciences team in the Netherlands. Frits is diligent and shown some in-depth knowledge in genetic engineering and immunology. He gets very involved in the matters, which is great from a client perspective.’

‘Sophie van Asten has a strong intellectual property law background and has worked on a number of life sciences cases. She is very easy to work with.’

Principaux clients

Life Sciences Partners


Xinvento


Frame Cancer Therapeutics


Consilient Health


Logex International Healthcare Analytics B.V


EURAZEO


DSM


Leydonlabs


Principaux dossiers


Hogan Lovells International LLP

Hogan Lovells International LLP‘s team has ‘excellent‘ expertise across a wide variety of areas, including orphan designations, pharma advertising, and supply chain structures. Practice head Hein van den Bos is well known for his IP and technology expertise, which he utilises to advise international pharma and biotech companies on EU marketing authorisation applications and disputes concerning data exclusivity. Bert Oosting is particularly skilled at handling international patent disputes before the European Patent Office (EPO), while Karen Jelsma assists clients with regulatory issues, including clinical trial agreements and distribution disputes. The ‘exceptionally intelligentGertjan Kuipers is a ‘sharp and gifted‘ litigator who primarily focuses on patent infringement cases.

Responsables de la pratique:

Hein van den Bos


Autres avocats clés:

Bert Oosting; Karen Jelsma; Gertjan Kuipers


Les références

‘I would follow Gertjan Kuipers anywhere!

‘Gertjan Kuipers is exceptionally intelligent and he is a sharp and gifted litigator. He will quickly learn any technology that is the subject of a litigation, and understands the big picture.’

‘Global scope, nice down-to-earth people and excellent expertise.’

Principaux clients

Ferring


Principaux dossiers


  • Assisted a US-based pharmaceutical company with its first marketing authorisation application before the European Medicines Agency for a remedy for a serious disease for which there are currently limited treatment options.
  • Conducted a European Medicines Agency and Dutch authority mock inspection regarding compliance with EU pharmacovigilance requirements.
  • Represented BMS in various patent proceedings relating to BMS’ product Eliquis® (apixaban).

Loyens & Loeff

The team at Loyens & Loeff acts for a lucrative, varied client base of healthcare insurance, diagnostics, and pharma companies on an array of regulatory, corporate, and tax related matters. The group regularly represents clients in administrative proceedings involving alleged breaches of transparency laws within the healthcare procurement process. Tom van Helmond, Kim Lucassen, and Vincent van der Lans jointly head the practice. Lucassen is well known for her expansive expertise in data protection and cybersecurity, advising a number of biotech companies and research institutions, while van Helmond is noted for his vast knowledge of procurement and competition issues and van der Lans maintains a tax-focused practice that encompasses a range of financing transactions and M&A. Regulatory expert Dieuwke Hooft Graafland handles a broad range of healthcare disputes concerning insurance and financing, in addition to advising on joint ventures and corporate governance. Céline van Waesberge left the team in June 2023.

Responsables de la pratique:

Tom van Helmond; Kim Lucassen; Vincent van der Lans


Autres avocats clés:

Marc Wiggers; Dieuwke Hooft Graafland; Aurélie Mingels; Hamza Zourakhti


Les références

‘Approachable, fast, excellent quality.’

‘Dieuwke Hooft Graafland is approachable, fast, delivers excellent quality, and is familiar with our company.’

‘The team excels in their expertise and willingness to help out.’

Principaux clients

AstraZeneca


Zilveren Kruis


Unilabs


Bergman Clinics


Zorgverzekeraars Nederland


European Investment Bank


Forbion


VGZ


Hartwig Medical Foundation


Laurens


EQT


Menzis


Amstelland Hospital


Medtronic


Orpea


Galapagos


Principaux dossiers


  • Advised AstraZeneca on Dutch legal (including life sciences regulatory), employment, and tax matters in connection with the acquisition of Neogene Therapeutics Inc., a global clinical-stage biotechnology company which will operate as a wholly owned subsidiary of AstraZeneca, with operations in Amsterdam and California.
  • Represented Zilveren Kruis in landmark procedures concerning the so-called impediment criterion, a case which the client won.
  • Assisted Unilabs Nederland B.V. with the acquisition of Laboratorium-Centrum voor Bedrijven (L.C.B.) and Atalmedial Holding B.V. from Stichting Atalmedial.

AKD

AKD‘s ‘remarkable, talented‘ team frequently assists healthcare providers with contractual issues and strategic alliances in addition to representing clients in proceedings against health insurers and government authorities. The group also advises a number of pharma, medtech, and biotech companies on matters concerning inducements and product advertising. The ‘sharp, genuineJoris Rijken co-heads the practice from Amsterdam, primarily acting for healthcare providers in matters concerning contracts with the Dutch Healthcare Authority and care procurement. Working out of the Eindhoven office, co-head Barbara Mutsaers is praised by clients for her ‘very keen eye‘ and is particularly skilled in advising on clinical trials, R&D agreements, and disputes against administrative fines.

Responsables de la pratique:

Joris Rijken; Barbara Mutsaers


Autres avocats clés:

Maartje de Jong; Marlou Jannink


Les références

‘The practice consists of remarkable, talented people who can be considered as an extension of your own organisation. They go the extra mile in times of need, and in times of opportunity. Together as a team they combine sector knowledge, legal knowhow and personal competence.’

‘I specifically work with Barbara Mutsaers, she has a very keen eye and is able to unravel complex issues and propose possible solutions. She feels very responsible and is taken into account the company’s interests.’

‘Barbara Mutsaers has been our legal aid on various matters and has done an exceptional job. She has been the thought leader and strategist around our legal position and has clear understanding of the commercial impact. She doesn’t need much explanation, digests a lot of info rapidly and produces a view/position instantly on the case. ’

Principaux clients

Stichting Zuyderland Medisch Centrum


Prinses Máxima Centrum voor Kinderoncologie B.V.


Dutch Association for General Practitioners


Dutch Association for Care for People with a Handicap


Dutch Association of Mental Health and Addiction Care


VGZ


Erasmus Medical Center


University Medical Center Utrecht


Salland Zorgverzekeraar


Maasziekenhuis Pantein B.V.


Reinier Haga Groep


Aevitae B.V.


Carante Groep


Almende B.V.


OLVG Lab B.V.


Merz Pharma Benelux B.V.


Alliance Healthcare Nederland B.V.


Vaxxinova International B.V.


Basic Pharma Holding B.V.


Kyowa Kirin Pharma B.V.


Erasmus Universitair Medisch Centrum Rotterdam


ISA Pharmaceuticals


Integris Health


Biomet 3i Netherlands B.V.


Zimmer Dental Inc.


Hestia Cardiovascular Service Center B.V.


Eurocom Healthcare Technology B.V.


Aevitae B.V.


Stichting Zuyderland Medisch Centrum


Principaux dossiers


  • Assisted University Medical Center Utrecht with an appeal procedure against the decision by the Ministry of Health to concentrate operations on children with congenital heart diseases in two other academic hospitals.
  • Advised Stichting Reinier Haga Groep on a demerger.
  • Advised the Dutch Association of General Practitioners on its participation in an agreement between the Ministry of Health and a number of associations of medical professionals and healthcare providers on the future of Dutch healthcare.

BarentsKrans

BarentsKrans is known for handling the full gamut of regulatory issues for hospitals, health insurers, and pharma companies. The Hague-based group is well-placed to advise on marketing authorisations, government healthcare programs, and patent disputes. Practice head and IP litigator Jaap Bremer has a great deal of experience in acting for technology clients, while also advising on non-contentious IP mandates, such as cooperation and distribution agreements. Competition and procurement specialist Tim Raats advises both tendering authorities and tenderers within the healthcare sector, with a particular emphasis on those in the youth mental healthcare and home care spaces. Raats is also noted for his broad knowledge of vertical agreements and merger filings.

Responsables de la pratique:

Jaap Bremer


Autres avocats clés:

Tim Raats; Marjolein van Rest


Les références

‘Good understanding of the sector; honest advice and – very importantly – on technology they have a great network with a few of the best patent attorneys.’

‘Jaap Bremer delivers on time and always to the point. Takes the extra step.’

‘Jaap Bremer is, simply, a fine patent lawyer with a first-class mind, combining his legal skills with practical commercial awareness.’

Principaux clients

Viatris


Stichting Haaglanden Medisch Centrum


Focus Care Pharmaceuticals


Supergarant Zorg


Medisch Specialisten Collectief RdGG UA


Advance Medical Designs


Pelvitec


GGZ Noord-Holland


Zilveren Kruis


OCRN B.V.


Vivisol Nederland B.V.


Principaux dossiers


  • Represented Viatris (Mylan) in multijurisdictional patent litigation initiated by Novartis with respect to fingolimod, an immunosuppressant drug used for treatment of multiple sclerosis.
  • Represented Advance Medical Designs, Leapmed and Pelvitec in patent infringement (first instance and appeal) proceedings initiated by Corbin Clinical Resources.
  • Advised the cooperative of medical specialists of the Reinier de Graaf Gasthuis on the planned merger with two other hospitals (HagaZiekenhuis and LangeLand Ziekenhuis) into the Reinier Haga Groep.

Bird & Bird

In The Hague, Marc van Wijngaarden and Michiel Wurfbain jointly lead the team at Bird & Bird, which maintains its strong reputation for advising clients on the regulatory, data, and privacy aspects of digital health mandates. The group advises biotech and pharma companies, and funds on their investments and listings. Wurfbain is noted for his vast expertise in advising on capital markets transactions and cross-border M&A, and van Wijngaarden is an IP specialist who acts for pharma, biotech, and medical device clients. Tjibbe Douma is adept at representing clients in EPO opposition proceedings and advising on UPC strategy, while Hester Borgers is known for her expertise in regulatory disputes and multi-jurisdictional patent litigation.

Responsables de la pratique:

Marc van Wijngaarden; Michiel Wurfbain


Autres avocats clés:

Wouter Pors; Tjibbe Douma; Hester Borgers


Les références

‘The team works hand in hand, and the brilliant communication skills of the team members allow them to communicate well with each other to find the best solutions, communicate well with collaboration partners to coordinate efforts, and communicate well with the client. They have a great understanding for the substance and the legal aspects of the cases.’

‘Tjibbe Douma is a great leader. He listens to his team and leads by example, not hierarchy. He always has the complete picture of the case, including in the context of international litigation. Furthermore, he is very convincing and very sharp in court.’

‘Hester Borgers has phenomenal communication skills and a great overview of the cases she works.’

Principaux clients

B Braun Melsungen


Fengh Medical


Oculentis


ConvaTec


Polpharma


Sanofi


Ablynx


Bicycle Therapeutics


Edwards Lifesciences


Chinook


Lonza Group


Veloxis Pharmaceuticals


Preceyes


Keygene


Ferring Pharmaceuticals


Scoutcam


Pet Service Holding


Neuraxpharm


Principaux dossiers


  • Represented Edwards Lifesciences in a multi-jurisdiction multi-patent dispute against Meril Life Sciences and its national distributor in light of Meril’s global launch at risk of their prosthetic heart valve Myval, which is, according to Edwards, a copy of their own prosthetic valve, the SAPIEN 3.
  • Rerpesented Neuraxpharm in a high profile, international patent litigation in the Netherlands against Biogen, which also involves regulatory aspects and concerns the introduction of Neuraxpharm DMF, which is prescribed as a treatment option for adults with relapsing multiple sclerosis and competes with Biogen’s blockbuster drug Tecfidera.
  • Assisted Swiss stock exchange listed Lonza Group AG with its acquisition of Synaffix B.V., a biotechnology company focused on commercialising its clinical-stage technology platform for the development of ADCs.

CMS

The team at CMS exhibits broad expertise across a diverse range of matters, including the restructuring of licenses, joint projects between pharma companies and healthcare institutions, and pricing and reimbursement negotiations. Practice head Ellen Gielen is known for her vast regulatory expertise, particularly in relation to pricing and reimbursement as well as manufacturing and distribution mandates. Judith Kok maintains a regulatory-focused practice, advising on the handling and marketing of medical devices and biocides, while Gertie Lintjens primarily advises clients in the pharma and medical device industries on early access issues and R&D projects, in addition to advertising and transparency disputes.

Responsables de la pratique:

Ellen Gielen


Autres avocats clés:

Judith Kok; Gertie Lintjens


Les références

‘Our contacts at CMS NL differ from many other lawyers in that they deliver practically usable results. They point out potential risks, but at the same time commit to an outcome and don’t leave us guessing. After the consultation, we are definitely smarter and know our options.’

‘Knowledgeable about our market environment, very pragmatic and able to translate legal means to business outcomes, easy to work with.’

‘Good and timely follow up, very collaborative and good overall communication.’

Principaux clients

LEO Pharma


Netherlands Cancer Institute


Nordmark Pharma GmbH


Rhythm Pharmaceuticals


Tonix


Vivus


Amgen


Brocacef


Eli Lilly


GE Healthcare


Principaux dossiers


De Brauw Blackstone Westbroek

De Brauw Blackstone Westbroek acts for a broad range of clients, including medical supply companies, investors in the sector, and high-profile pharma companies. Joining the team in July 2023 from NautaDutilh, practice co-head Anne Marie Verschuur is noted for her skill in advising on UPC issues and patent infringement actions, while IP litigator Tobias Cohen Jehoram frequently appears before the Supreme Court of the Netherlands in patent cases on behalf of high-profile pharma companies. Reinier Kleipool has broad expertise in handling corporate governance issues, and private equity expert Lennard Keijzer primarily advises on governance arrangements between co-investors and private equity funds. Bertrand ter Woort maintains an IP and tech focused practice, frequently assisting clients with R&D collaborations and licensing issues.

Responsables de la pratique:

Tobias Cohen Jehoram; Reinier Kleipool; Anne Marie Verschuur; Lennard Keijzer


Autres avocats clés:

Bertrand ter Woort


Principaux clients

Advanced Bionics


Affimed N.V.


Almirall B.V.


Amgen


Arya Sciences Acquisition Corp


AstraZeneca


Biogen


Bureau Clara Wichmann


Coloplast A/S


Eli Lilly


Ferring


Forbion


G Square


IGEA Pharma N.V.


Illumina


Jefferies LLC


Koninklijke Philips N.V.


MSD


Pharmathen


Qiagen


Sandoz B.V.


Synthon Holding B.V.


Triton Investment Management Limited


UMCG


Zimmer Biomet


Principaux dossiers


  • Represented Pharmathen Global B.V. in patent proceedings against Novartis A.G. before the Dutch Supreme Court.
  • Represented Philips in proceedings relating to claims by patients in connection with sleep apnea devices.
  • Acted as Dutch legal counsel for the underwriters on NewAmsterdam Pharma N.V.’s secondary offering of shares.

Houthoff

Primarily based in Amsterdam, the team at Houthoff dispays vast experience in advising on competition mandates, with particular emphasis on merger clearance and investigations, in addition to damages claims. Practice co-head Weijer VerLoren van Themaat is noted for his broad expertise in acting for hospitals and private clinics in cases against public authorities and restructurings, while co-head Freeke Heijne primarily handles regulatory matters for healthcare insurers and investors. Rotterdam-based litigator Huib Lebbing represents clients in class actions and collective claims, having deep knowledge of contractual liability related disputes. Having previous experience working for the Dutch Healthcare Authority, Murat Duman is well-placed to represent associations of hospitals and private clinics in cases before government authorities.

Responsables de la pratique:

Weijer VerLoren van Themaat; Freeke Heijne


Autres avocats clés:

Huib Lebbing; Greetje van Heezik; Murat Duman


Les références

‘The team communicates in a clear and sharp way. Practical and trustworthy. Has extensive knowledge and track record in competition law. Is always available for questions and support. ’

‘Expertise, quality, accessible consultation, thorough.’

Principaux clients

Amsterdam UMC


Bergman Clinics


Equipe Zorgbedrijven


ZKN


GIMV


Leger des Heils


ONVZ


The Dutch State


William Schrikker Groep


Ottobock


Principaux dossiers


  • Represented the Ministry of Public Health, Welfare and Sport in proceedings related to claims of damages by the Dutch Trade Union Confederations FNV and CNV for potentially thousands of healthcare workers.
  • Acted for Bergman Clinics in a court procedure against the decision by the Dutch Competition Authority to block the acquisition of Mauritskliniek.
  • Acted for an individual caretaker and the largest Dutch women’s right organization Bureau Clara Wichmann in litigation against the applicability of a regulation dating from 1930s.

NautaDutilh

The group at NautaDutilh displays vast expertise in handling a broad array of corporate matters for its varied client list, including seed rounds, share offerings, and private placement financings. Practice co-head Ruud Smits has a great deal of transactional expertise within the healthcare and life sciences space, advising start-ups and investors on M&A and VC-backed financing rounds. Co-head Jeroen Boelens is an IP specialist who focuses on technology within the pharma and biotech spaces, frequently assisting clients with biotech IPOs and licensing M&A. Anne Marie Verschuur departed the practice in May 2023.

Responsables de la pratique:

Ruud Smits; Jeroen Boelens


Autres avocats clés:

Paul van der Bijl; Joppe Schoute


Les références

‘Ruud Smits is extremely engaged and knowledgeable about the sector. He is able to negotiate in a very businesslike manager which manages complex cross-cultural situations perfectly.’

‘NautaDutilh’s team is highly professional and pragmatic. They understand the client need and do not just use cookie-cutter approaches.’

Principaux clients

Forbion


NewAmsterdam Pharma


Pharvaris


GSK


Rhythm Pharmaceutcials


Avania


Ginkgo


The Protein Brewery


Lumicks


Mimetas


Pharmathen


Galenicum


Principaux dossiers


  • Advised Synaffix on its sale to Lonza Group AG for up to $160m.
  • Advised NewAmsterdam Pharma on its upsized Secondary Offering of Ordinary Shares and its $726m business combination with Frazier Lifesciences Acquisition Corp.
  • Advised Neogene Therapeutics on its sale to AstraZeneca for up to €320m.

Simmons & Simmons

Simmons & Simmons is adept at handling the full spectrum of disputes, with particular emphasis on product liability, SPC extensions, and EPO proceedings. The team is jointly led by Johan Renes and Bas Berghuis van Woortman. With longstanding IP expertise, Renes represents clients in patent disputes and non-contentious matters, including license and collaboration agreements, and the securing of investments. Berghuis van Woortman advises numerous pharma, biotech, and medical device clients in IP disputes and R&D agreement negotiations. Oscar Lamme is known for acting in multijurisdictional mandates concerning patent and competition law.

Responsables de la pratique:

Johan Renes; Bas Berghuis van Woortman


Autres avocats clés:

Oscar Lamme; Ekram Belhadj; Guido Fazzi


Principaux clients

Alnylam


Alcon


GlaxoSmithKline


Wright Medical


Eli Lilly


Gilead Sciences


Lundbeck


Terumo


Coloplast


Netherlands Cancer Institute


Bayer Healthcare


Samsung Bioepis


DC Prime


Seattle Genetics Inc.


Sint Maartenskliniek


Medicxi


Align Technology


Serenity Pharmaceuticals


Médecins sans frontiers


Unicef


Zimmer Biomet


Thebe


Principaux dossiers


  • Acted for Samsung Bioepis in litigation against competitor biosimilars company Fresenius in respect of revocation and infringement proceedings pertaining to the formulation of its successful adalimumab biosimilar, Imraldi®, and in a successful litigation listed against Gedeon Richter in respect of revocation and infringement proceedings pertaining to the formulation of its adalimumab biosimilar.
  • Represented uniQure in uniQure vs. Pfizer, coordinating multiple IPR proceedings regarding the validity of uniQure’s US patents covering its phase III clinical product for the treatment of hemophilia B.

Van Doorne

Willemien Bischot and Dimitri van Hoewijk jointly lead the team at Van Doorne, which is noted for its vast expertise in healthcare governance, particularly from a regulatory perspective. The group also handles numerous digital health mandates involving patient data. Healthcare specialist Bischot primarily advises academic hospitals, and elderly and special needs providers with corporate governance and funding issues, while van Hoewijk focuses on market access, often assisting pharma companies and investors with reimbursement matters. Louis Jonker is an expert in technology who has vast regulatory knowledge, particularly in relation to digital innovations and disruptive tech. Tax specialist Daniëlle Westerhoff advises on M&A and collaborations, while Siego Boslooper is well-versed in handling restructuring and corporate governance-related mandates.

Responsables de la pratique:

Willemien Bischot; Dimitri van Hoewijk


Autres avocats clés:

Louis Jonker; Nick Suurmond; Daniëlle Westerhoff; Siego Boslooper


Les références

‘Dimitri van Hoewijk is very knowledgeable, fair but strong in negotiations, sharp on details.’

‘What I find unique is the seamless collaboration between lawyers with diverse specialisations-’

‘Van Doorne has a multidisciplinary team of lawyers who specialise in health law. As a result, they are able to provide clients with good and specialist support with a broad view. They are flexible and quickly deployable. ’

Principaux clients

Arthrex GmbH


Belmont Instrument, LLC


Field Trip Health B.V.


Veonet GmbH


Stichting Kinderen Kankervrij


Link Nederland B.V.


OM Pharma SA


Symeres Netherlands B.V.


QurAlis Netherlands B.V.


Lumanity


Erasmus MC


Mentaal Beter


Gelre Ziekenhuizen


Albert Schweitzer Ziekenhuis


Ksyos


Amsterdam UMC


ORPEA


Buurtzorg


ZRTI


Mediq


NKI/AVL


Amerpoort


Navitas


NPM Capital


Zaans Medisch Centrum


Domus Magnus


Rijnstate


Interakt Contour


GGZ Eindhoven


GGZ InGeest


Principaux dossiers


  • Advised two academic hospitals in Amsterdam, VUmc and AMC, on their collaboration and merger.
  • Advised Gelre Ziekenhuizen on the outsourcing of its medical laboratories to Eurofins.
  • Advised Erasmus MC from a legal and strategic perspective on the Minister’s decision to close down two of the four paediatric heart surgery centers in the Netherlands and also represented the client in related administrative proceedings.

Dirkzwager

Dirkzwager houses a broad team, predominantly based in Nijmegen, which is known for representing healthcare providers and medical specialists across the Netherlands in matters involving data leaks, civil disputes, and employment law. Practice co-head Koen Mous is known for his expertise in civil law, handling a vast range of matters including in relation to the procurement of healthcare services and the organisation of specialist medical care within hospitals. Co-head Marieke van Dongen primarily advises the supervisory boards as well as boards of directors of numerous hospitals, mental health institutions, and independent treatment centres on partnerships and M&A.

Responsables de la pratique:

Koen Mous; Marieke van Dongen


Les références

‘I have worked with Marieke van Dongen is very professional with a lot of knowledge in the field. Always understanding. Giving options if possible with the risks and probabilities of success. ’

‘Koen Mous and Luuk Arends are experienced, friendly and willing to discuss and explain (and adjust minor parts of) their advice. ’

‘Marieke van Dongen is knowledgeable and good to work with. Trustworthy and competent. ’

Principaux clients

Sint Maartenskliniek


Deventer Ziekenhuis


ETZ


Rijnstate Ziekenhuis


Landelijke Huisartsen Vereniging


Pluryn


NVZ Nederlandse Vereniging van Ziekenhuizen


Bravis Ziekenhuis


Oogziekenhuis Rotterdam


Pro Persona


Canisius-Wilhelmina Ziekenhuis


Archipel


Stichting Revalidatiegeneeskunde Nederland


Principaux dossiers


  • Represented multiple healthcare providers in a case concerning their ability to provide healthcare in the Dutch healthcare system without being contracted by a healthcare insurer.
  • Represented care provider Stichting Pluryn in a dispute with the municipality of Lelystad, resulting in a successful verdict stating that the municipality could not use the statute of limitations as a reason to refuse reimbursement of healthcare costs.
  • Represented multiple large hospitals and healthcare institutions in the Netherlands during contract negotiations with integrated Electronic Health Record/Hospital Information System/eHealth system suppliers, which involved terminating existing contracts, arranging migrations to new suppliers, and negotiating with leading providers such as ChipSoft and emerging suppliers such as NEXUS.

Kennedy Van der Laan

A 'large team with very broad and in-depth knowledge', Kennedy Van der Laan‘s practice is known for advising a diverse range of medical device companies and institutes, with a particular specialism in the oncology space. Practice co-head Fenna van Dijk is noted for her longstanding corporate expertise, advising numerous directors of healthcare institutions and branch organisations on collaborations and M&A, while Eline Lam is well versed in governance and collaboration mandates. IP specialist and co-head Maarten Schut is particularly adept at handling matters concerning trade secrets and publishing for academic hospitals and other not-for-profit institutions. Additionally, Schut regularly represents clients in negotiations and disputes concerning R&D and licensing. Anne ten Brummelhuis has vast knowledge of patient rights, tariff regulation, the Youth Act, and the Social Support Act, allowing her to handle a range of e-health and regulatory mandates.

Responsables de la pratique:

Fenna van Dijk; Maarten Schut


Autres avocats clés:

Eline Lam; Joran Spauwen; Anne ten Brummelhuis


Les références

They have a large team with very broad and in-depth knowledge. They also provide helpful knowhow to keep us up to date.’

‘In particular Anne ten Brummelhuis stands out from the crowd. She can provide on the spot and to the point advice and is very responsive.’

‘Eline Lam has a great sense of our organisation’s needs and level of advice. Anne ten Brummelhuis is a reliable expert.’

Principaux clients

Aidsfonds


Arts en Zorg


GezondheidsZorg Asielzoekers Nederland B.V.


Certis


Cytosen Therapeutics


Desktop Genetics


Ergomed


Gadeta


GGD Amsterdam


GGD GHOR / LCCB


GGZ inGeest


Heliomare


Huisartsenposten Rijnmond


HVO-Querido


Insight RX


Intravacc


IXA


Landelijke Huisartsenvereniging


Mentaal Beter


Modify


NHG


Nutreco


Odion


Oncode Institute


Oncode-PACT


Reade


Reinier Haga Medisch Diagnostisch Centrum


Stichting Apotheek Haagse Ziekenhuizen


Stichting Kinderoncologie Nederland


Syngenta


VECOZO


VU Medical Centre


Principaux dossiers


  • Advised Oncode Institute on the renewal of the Affiliation Agreement with the 13 affiliated partner institutions and the renewal of the contribution agreement with its main funder, KWF Kankerbestrijding.
  • Advised Intravacc on cross border R&D co-operations, license contracts and other contract negotiations with business partners around the world, including co-operations to develop a Covid-19 vaccine.
  • Advised LHV, the national association for general practitioners, on a revision of the manner in which it was organised, including its governance, entailing among the merger with over 20 regional associations of GP’s, including the transfer of their activities to the national association, among other aspects.

Maverick Advocaten N.V.

Competition law boutique Maverick Advocaten N.V. is well-known for handling merger and administrative proceedings before the Netherlands Authority for Consumers and Markets as well as the Dutch Healthcare Authority. Praised for his ‘outstanding‘ knowledge, practice co-head Diederik Schrijvershof acts for pharma companies and healthcare providers in court proceedings against prohibition decisions, in addition to competition disputes involving tariffs, while co-head Martijn van de Hel regularly acts in approval proceedings concerning joint ventures and takeovers.

Responsables de la pratique:

Diederik Schrijvershof; Martijn van de Hel


Les références

‘Collaboration with the team at Maverick is great. They are flexible, responsive and pragmatic. ’

‘Martijn is an easy accessible partner who is energetic, hands-on and on the ball. He gives confidence that the case is in good hands. We trust him he and his team to go the extra mile. ’

‘Their knowledge is up to date and they are always willing to act as a critical sounding board.’

Principaux clients

Asker


Achmea


Mediq


RadboudUMC


Parnassia Groep


Erasmus MC


Gilde Healthcare Partners B.V.


De Nederlandse GGZ


Dianet


GenomeScan


Stichting De Forensische Zorgspecialisten


NVOS-Orthobanda


University Medical Center Groningen


Leiden University Medical Centre


Regiozorg


Leven & Zorg


De Bevlogen Huisartsen


WVO Zorg


Principaux dossiers


  • Represented Mediq in successful court proceedings against a prohibition decision of the ACM for the acquisition of Eurocept Homecare and Excellent Clinics.
  • Assisted Penders Voetzorg and OIM with the proposed acquisition of a part of OIM by Penders.
  • Advised Stichting De Bevlogen Huisartsen on the nationwide Integral Care Agreement.

Pels Rijcken & Droogleever Fortuijn NV

Based in The Hague, Wemmeke Wisman, Marije Batting, Elisabeth Pietermaat jointly co-lead the team at Pels Rijcken & Droogleever Fortuijn NV, which is known for handling the full spectrum of healthcare-related matters for the Dutch Government and healthcare providers. Wisman is a litigation expert who often acts in civil procedures concerning the fundamental right to medical treatment. Batting leads the public law practice at the firm, primarily handling issues relating to quality of care, with particular emphasis on the approval of medicines, in addition to pricing and reimbursement mandates, while Pietermaat is noted for her extensive regulatory expertise, with her primary area of focus being the financing of healthcare.

Responsables de la pratique:

Wemmeke Wisman; Marije Batting; Elisabeth Pietermaat


Autres avocats clés:

Jorrit van de Weide; Paul Tanja


Les références

‘Pels Rijcken are extremely good in what they do, practical dispute resolution is a big part of their practice. Due to the climbing amount of disputes regarding the Covid-19 crisis I have seen the team evolve into smart attorneys focused on serving the interests of the State. This means navigating complex political interests and influences.’

‘I work mostly with Paul Tanja. He excels in corporate litigation and litigation before the Supreme Court/Court of Appeal. I prefer working with him because he is sharp but practical. He has all details in clear vision, but yet focuses on the big picture. His skill in finding exactly the right tone and approach with every opponent is something that is rare in attorneys belong amongst the best in their field of expertise.’

‘The healthcare team has an excellent knowledge of healthcare and its legal aspects. Like no other, the team is attentive to the public law playing field in which issues arise.’

Principaux clients

Nederlandse Zorgautoriteit


IGJ


CZ


Menzis


VGZ


Zorgverzekeraars Nederland


Zorginstituut Nederland


The State of the Netherlands


Florence


CBG


Zilveren Kruis


Domus Magnus


Stichting Cordaan


Principaux dossiers


  • Represented the Ministry of Health, Welfare and Sport in proceedings commenced by several university hospitals with regards to the decision to keep only two children’s heart surgery centres in the Netherlands.
  • Advised the Ministry of Health, Welfare and Sport in connection with the contract with Relief Goods Alliance for the sale of protective faces masks.
  • Represented CZ as well as VGZ and Menzis in civil proceedings regarding the reimbursement of the costs of healthcare for a non-contracted healthcare provider as well as in proceedings regarding patients’ free choice of medical practitioner.

Pinsent Masons LLP

Pinsent Masons LLP‘s team is noted for its vast knowledge of IP issues within the life sciences space. Practice head Judith Krens is particularly adept at acting in SPC and cross-border patent disputes, in addition to advising on regulatory mandates concerning pharma and medical device law. Krens is also noted for her expertise in non-contentious IP related matters, including transfer agreements and IP licenses. In May 2023, András Kupecz left the team to become a judge at the Unified Patent Court, and Machteld Hiemstra also departed the practice.

Responsables de la pratique:

Judith Krens


Autres avocats clés:

Arjan Reijns; Marthe Riewald


Principaux clients

Teva Pharmaceutical Industries Limited


Accord Healthcare Limited


Fresenius Kabi


Principaux dossiers


  • Acted for Teva in proceedings in the Dutch Court against Bristol-Myers Squibb in relation to the blockbuster anticoagulant drug Eliquis.